Our Resource Library
From in-depth blogs and ebooks to on-demand webinars and practical checklists, look here for ideas and insight to support your strategic decisions and best practices in compliance, management, coaching, pricing, and more.
Recent Blogs
Discover our most recently published blogs and articles.
-
MediSpend and Life Sciences Subsidiary of RLDatix Merge to Form Leading Global Provider of Regulatory and Compliance SaaS Solutions for Life Sciences
New company delivers built-for-purpose, best-in-class solutions spanning the entire product lifecycle for pharmaceutical, biotech, and medical device companies September 2nd, 2025 – MediSpend and RLDatix Life Sciences, a subsidiary of RLDatix, today announced a definitive agreement to merge, creating a new unified company at the forefront of… Read More
-
PHS Pricing Under Pressure: Managing Duplicate Discounts and Diversion Risks in 2025
Duplicate discounts and diversion are two of the most persistent risks in pharmaceutical pricing, and in 2025, they’re under the microscope. HRSA audits are tougher, state-level carve-in/carve-out rules are more complex, and manufacturers are expected to prove not only that they have controls in place, but that those controls are… Read More
-
HRSA Launches 340B Rebate Model Pilot Program: What Manufacturers Need to Know
The Health Resources and Services Administration (HRSA) has introduced a significant new development for the 340B Drug Pricing Program with the launch of its 340B Rebate Model Pilot Program. This initiative offers drug manufacturers a fresh, alternative pathway to comply with their 340B pricing obligations, aimed at addressing longstanding industry… Read More
-
Modernizing Customer Class of Trade Management: Best Practices for Clean Segmentation & Contracting
If your Class of Trade (COT) data isn’t clean, your entire revenue management process is at risk. From chargebacks to government pricing, every downstream calculation depends on getting COT right. And in today’s marketplace, the margin for error is shrinking fast. With IDNs, specialty… Read More
-
What It Takes to Launch in 2025: MFN, MFP, IRA, and the New Rules of the Road
Launching a drug in today’s market is all about navigating the right path. With Most Favored Nation (MFN) policies under discussion, Maximum Fair Price (MFP) requirements taking shape, and Inflation Reduction Act (IRA) provisions already impacting revenue models, pharmaceutical manufacturers face a gauntlet of regulatory checkpoints before, during, and after… Read More
-
How 2025 Is Changing Sunshine Act Compliance: What Life Sciences Companies Need to Know
The Sunshine Act landscape is shifting rapidly in 2025, bringing new challenges and opportunities for life sciences companies. Increased regulatory scrutiny, evolving audit protocols, and the rise of advanced technologies, such as artificial intelligence (AI), are reshaping how organizations approach compliance. Here’s what your business needs to know to stay… Read More
Recommended Reading
What is top of mind in Life Sciences? Check out this curated collection of our most popular resources and articles.
-
RLDatix Life Sciences: A pioneering merger of Porzio Life Sciences, iContracts and iCoachFirst
This incorporation will propel innovation in life sciences technology solutions. Morristown, NJ | January 18, 2024: RLDatix Life Sciences announces the integration of Porzio Life Sciences, iContracts, and iCoachFirst. This strategic union – a business unit of RLDatix, the leading global provider of connected healthcare operations software and services – marks… Read More